Annual EBIT
-$67.83 M
-$14.33 M-26.78%
December 31, 2023
Summary
- As of February 7, 2025, ATXS annual earnings before interest & taxes is -$67.83 million, with the most recent change of -$14.33 million (-26.78%) on December 31, 2023.
- During the last 3 years, ATXS annual EBIT has fallen by -$30.40 million (-81.20%).
- ATXS annual EBIT is now -274.36% below its all-time high of -$18.12 million, reached on December 31, 2013.
Performance
ATXS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$29.01 M
-$211.00 K-0.73%
September 30, 2024
Summary
- As of February 7, 2025, ATXS quarterly earnings before interest & taxes is -$29.01 million, with the most recent change of -$211.00 thousand (-0.73%) on September 30, 2024.
- Over the past year, ATXS quarterly EBIT has dropped by -$8.78 million (-43.38%).
- ATXS quarterly EBIT is now -549.23% below its all-time high of -$4.47 million, reached on March 31, 2014.
Performance
ATXS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$100.97 M
-$8.78 M-9.52%
September 30, 2024
Summary
- As of February 7, 2025, ATXS TTM earnings before interest & taxes is -$100.97 million, with the most recent change of -$8.78 million (-9.52%) on September 30, 2024.
- Over the past year, ATXS TTM EBIT has dropped by -$37.85 million (-59.96%).
- ATXS TTM EBIT is now -2159.28% below its all-time high of -$4.47 million, reached on March 31, 2014.
Performance
ATXS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATXS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.8% | -43.4% | -60.0% |
| 3 y3 years | -81.2% | -43.4% | -60.0% |
| 5 y5 years | -163.2% | -43.4% | -60.0% |
ATXS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.4% | at low | -205.2% | at low | -232.5% | at low |
| 5 y | 5-year | -150.4% | at low | -430.1% | at low | -272.7% | at low |
| alltime | all time | -274.4% | at low | -549.2% | at low | -2159.3% | at low |
Astria Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.01 M(+0.7%) | -$100.97 M(+9.5%) |
| Jun 2024 | - | -$28.80 M(+19.3%) | -$92.19 M(+17.5%) |
| Mar 2024 | - | -$24.15 M(+27.1%) | -$78.49 M(+15.7%) |
| Dec 2023 | -$67.83 M(+26.8%) | -$19.00 M(-6.1%) | -$67.83 M(+7.5%) |
| Sep 2023 | - | -$20.24 M(+34.0%) | -$63.12 M(+14.2%) |
| Jun 2023 | - | -$15.10 M(+11.9%) | -$55.27 M(+7.1%) |
| Mar 2023 | - | -$13.49 M(-5.6%) | -$51.62 M(-3.5%) |
| Dec 2022 | -$53.50 M(+76.2%) | -$14.29 M(+15.4%) | -$53.50 M(+9.8%) |
| Sep 2022 | - | -$12.39 M(+8.2%) | -$48.72 M(+10.1%) |
| Jun 2022 | - | -$11.45 M(-25.5%) | -$44.23 M(+9.8%) |
| Mar 2022 | - | -$15.38 M(+61.7%) | -$40.27 M(+32.6%) |
| Dec 2021 | -$30.36 M(-18.9%) | -$9.51 M(+20.4%) | -$30.36 M(+1.8%) |
| Sep 2021 | - | -$7.90 M(+5.5%) | -$29.84 M(-9.0%) |
| Jun 2021 | - | -$7.49 M(+36.8%) | -$32.80 M(-5.9%) |
| Mar 2021 | - | -$5.47 M(-39.0%) | -$34.87 M(-6.9%) |
| Dec 2020 | -$37.44 M(+38.2%) | -$8.98 M(-17.4%) | -$37.44 M(+6.3%) |
| Sep 2020 | - | -$10.86 M(+13.7%) | -$35.20 M(+13.5%) |
| Jun 2020 | - | -$9.55 M(+18.8%) | -$31.02 M(+7.7%) |
| Mar 2020 | - | -$8.04 M(+19.2%) | -$28.80 M(+6.3%) |
| Dec 2019 | -$27.09 M | -$6.75 M(+1.0%) | -$27.09 M(+2.6%) |
| Sep 2019 | - | -$6.68 M(-8.8%) | -$26.40 M(+4.0%) |
| Jun 2019 | - | -$7.33 M(+15.6%) | -$25.39 M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$6.33 M(+4.5%) | -$24.51 M(-4.9%) |
| Dec 2018 | -$25.77 M(-4.2%) | -$6.06 M(+6.9%) | -$25.77 M(+2.6%) |
| Sep 2018 | - | -$5.67 M(-12.1%) | -$25.13 M(-4.7%) |
| Jun 2018 | - | -$6.45 M(-15.1%) | -$26.37 M(-1.5%) |
| Mar 2018 | - | -$7.59 M(+40.2%) | -$26.77 M(-0.5%) |
| Dec 2017 | -$26.90 M(-23.6%) | -$5.42 M(-21.6%) | -$26.90 M(-10.6%) |
| Sep 2017 | - | -$6.91 M(+0.9%) | -$30.09 M(-4.2%) |
| Jun 2017 | - | -$6.85 M(-11.4%) | -$31.40 M(-7.0%) |
| Mar 2017 | - | -$7.73 M(-10.2%) | -$33.77 M(-4.1%) |
| Dec 2016 | -$35.22 M(+11.3%) | -$8.60 M(+4.7%) | -$35.22 M(-2.0%) |
| Sep 2016 | - | -$8.22 M(-10.9%) | -$35.96 M(+0.0%) |
| Jun 2016 | - | -$9.22 M(+0.5%) | -$35.94 M(+4.2%) |
| Mar 2016 | - | -$9.18 M(-1.7%) | -$34.48 M(+8.9%) |
| Dec 2015 | -$31.65 M(+46.0%) | -$9.34 M(+13.8%) | -$31.65 M(+12.3%) |
| Sep 2015 | - | -$8.20 M(+5.7%) | -$28.19 M(+8.6%) |
| Jun 2015 | - | -$7.76 M(+22.2%) | -$25.96 M(+10.2%) |
| Mar 2015 | - | -$6.35 M(+8.1%) | -$23.56 M(+8.7%) |
| Dec 2014 | -$21.68 M(+19.6%) | -$5.88 M(-1.5%) | -$21.68 M(+37.2%) |
| Sep 2014 | - | -$5.97 M(+11.3%) | -$15.80 M(+60.7%) |
| Jun 2014 | - | -$5.36 M(+20.0%) | -$9.83 M(+120.0%) |
| Mar 2014 | - | -$4.47 M | -$4.47 M |
| Dec 2013 | -$18.12 M | - | - |
FAQ
- What is Astria Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Astria Therapeutics?
- What is Astria Therapeutics annual EBIT year-on-year change?
- What is Astria Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Astria Therapeutics?
- What is Astria Therapeutics quarterly EBIT year-on-year change?
- What is Astria Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Astria Therapeutics?
- What is Astria Therapeutics TTM EBIT year-on-year change?
What is Astria Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ATXS is -$67.83 M
What is the all time high annual EBIT for Astria Therapeutics?
Astria Therapeutics all-time high annual earnings before interest & taxes is -$18.12 M
What is Astria Therapeutics annual EBIT year-on-year change?
Over the past year, ATXS annual earnings before interest & taxes has changed by -$14.33 M (-26.78%)
What is Astria Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ATXS is -$29.01 M
What is the all time high quarterly EBIT for Astria Therapeutics?
Astria Therapeutics all-time high quarterly earnings before interest & taxes is -$4.47 M
What is Astria Therapeutics quarterly EBIT year-on-year change?
Over the past year, ATXS quarterly earnings before interest & taxes has changed by -$8.78 M (-43.38%)
What is Astria Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ATXS is -$100.97 M
What is the all time high TTM EBIT for Astria Therapeutics?
Astria Therapeutics all-time high TTM earnings before interest & taxes is -$4.47 M
What is Astria Therapeutics TTM EBIT year-on-year change?
Over the past year, ATXS TTM earnings before interest & taxes has changed by -$37.85 M (-59.96%)